Shorted
Cochlear logo
COH
Health Care Equipment & Services

Cochlear

Short interest
1.91%
−0.34 pp 30d
as of 13 Oct 2026
Reported shorts
1.2M
Shares on issue
65.399M

Cochlear (COH) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
7 Oct

Where Does Cochlear (ASX:COH) Stand After Class Action News?

Highlights Cochlear has been served with a class action in the Supreme Court of Victoria over its earlier underlying earnings forecast and has said it will defend the claim. The hearing implant maker has also completed recruitment for its global pivotal trials of fully implantable hearing technology in the US and Europe. The developments follow Cochlear's removal from the S&P/ASX index of the largest local companies in the September rebalance. Cochlear (ASX:COH) enters October balancing l...

Continue reading
Kalkine
Positive
6 Oct

Cochlear (ASX:COH) Shares Rebound Amid Legal Dispute

Highlights Cochlear is facing a shareholder class action in the Supreme Court of Victoria over its financial-year profit forecast. The hearing implant specialist has seen renewed market attention after a sharp period of share price weakness. Conflicting valuation models are adding another layer of debate around the healthcare stock. Australias share market is seeing renewed attention on healthcare names as company-specific developments continue to shape trading sentiment. Among the stock...

Continue reading
Kalkine
Positive
24 Sept

How Is Cochlear Rebuilding After Its Dividend Cut (ASX:COH)?

Highlights Cochlear's shares traded without entitlement to a sharply reduced final dividend earlier this week, with payment due in October. The company announced a new independent non-executive board appointment last week, effective from December. The hearing implant maker is working to rebuild confidence after cutting earnings guidance earlier this year. Cochlear (ASX:COH) is in focus today after its shares began trading without entitlement to a sharply reduced final dividend earlier this we...

Continue reading
Kalkine
Neutral
22 Sept

What Does Cochlear (ASX:COH) Mean for Healthcare?

Highlights Cochlear Limited (ASX:COH) develops and manufactures hearing implant technology used worldwide. Its device-focused business model places it distinctly within the Healthcare Stocks category. Global surgical volumes and healthcare access remain central to its performance. Medical device makers occupy a distinct corner of the healthcare landscape, and Cochlear Limited (ASX:COH) stands out as one of the more recognisable names in that space. As a developer of hearing implant technology...

Continue reading
Kalkine
Neutral
17 Sept

What Does Cochlear (ASX:COH) Mean for Healthcare Stocks?

Highlights Cochlear Limited (ASX:COH) develops and manufactures hearing implant technology used worldwide. Its device-focused business model places it distinctly within the Healthcare Stocks category. Global surgical volumes and healthcare access remain central to its performance. Medical device makers occupy a distinct corner of the healthcare landscape, and Cochlear Limited (ASX:COH) stands out as one of the more recognisable names in that space. As a developer of hearing implant technology...

Continue reading
Kalkine
Neutral
17 Sept

State Street Corporation Reduces Substantial Holding in Cochlear Limited to 7.17% as of September 2026

Cochlear Limited (ASX:COH) has been notified of a change in substantial holdings by State Street Corporation and its subsidiaries, revealing a decrease in their relevant interest in Cochlear ordinary shares as of 15 September 2026, with voting power declining from 8.27% to 7.17%. Key Points State Street Corporation's voting power in Cochlear Limited dropped from 8.27% to 7.17% on 15 September 2026. The prior substantial holding notice was submitted to Cochlear on 2 September 2026, dated 31 Au...

Continue reading
Kalkine
Positive
14 Sept

Are Cochlear (ASX:COH) Implant Upgrades Winning Clinicians?

Highlights The hearing implant maker reported annual profit at the upper end of its revised guidance range. [ASX 100] Its newest implant platform, built around upgradeable firmware, swiftly dominated unit demand in developed markets. Margin pressure persisted as emerging market volumes carried a greater share of the overall mix. Cochlear (ASX:COH) delivered annual profit at the top of its revised guidance range, with its newest implant platform rapidly taking over unit demand across developed...

Continue reading
Kalkine
Neutral
11 Sept

How Is Cochlear (ASX:COH) Facing Softer Implant Demand?

Highlights A reduced profit outlook has reset expectations for the hearing implant maker. Hospital capacity limits and fewer referrals have slowed surgical volumes in developed markets. Middle East conflict has added order cancellation and delivery risk to the mix. Cochlear (ASX:COH) spent the week caught in a healthcare rout that pushed the local benchmark to a fresh low for the year, with the hearing implant maker still absorbing the consequences of a reduced profit outlook that lowered the...

Continue reading
Kalkine
Neutral
6 Sept

Cochlear (ASX:COH), 4DMedical (ASX:4DX) and Telix(ASX:TLX): 3 ASX Healthcare Stocks

Highlights Cochlear, 4DMedical and Telix Pharmaceuticals feature in a cash-flow-focused value screen covering Australian healthcare companies. The three businesses have very different revenue models, ranging from established hearing devices to respiratory imaging and radiopharmaceuticals. Valuation discounts sit alongside different business conditions, including margin pressure, development spending, capital requirements and regulatory considerations. The Australian stock market has a br...

Continue reading
Kalkine
Neutral
4 Sept

UBS Group AG Ends Status as Substantial Shareholder in Cochlear Limited

Cochlear Limited (ASX:COH) announced that UBS Group AG along with its related entities ceased to be a substantial holder in the company as of 2 September 2026, as revealed in a Form 605 submission filed with the exchange on 4 September 2026. Key Points UBS Group AG and its related bodies corporate ended their substantial holding in Cochlear Limited on 2 September 2026. The prior substantial holding notification was submitted on 2 September 2026, referencing 31 August 2026. Changes in relevant...

Continue reading
Kalkine
Neutral
3 Sept

Does Cochlear (ASX:COH) Bring to the Healthcare Stocks Theme?

Highlights United States regulators cleared Cochlear's newest rechargeable Osia bone conduction sound processor. The redesigned processor drops disposable batteries entirely and adds direct streaming from consumer devices. Existing Osia implant recipients are expected to be able to upgrade without further surgery. Cochlear Limited (ASX:COH), the Sydney-based hearing implant maker, said its newest Osia Sound Processor has cleared United States regulatory review, a milestone for the [ASX 50] co...

Continue reading
Kalkine
Neutral
1 Sept

What Could Make Cochlear (ASX:COH) a Key Name Among Healthcare Stocks?

Highlights Cochlear delivered underlying net profit at the upper end of its reset guidance range. The Nexa implant platform reached near-complete adoption across developed market unit volumes. Operating cash flow strengthened markedly even as reported margins absorbed discrete charges. Cochlear (ASX:COH), the Sydney-based hearing implant maker that supplies clinics across a wide spread of markets, emerged from the August reporting stretch with underlying profit at the upper end of its reset g...

Continue reading
Kalkine
Neutral
31 Aug

Why Could Cochlear (ASX:COH) Matter for Value Stocks?

Highlights Discounted cash flow screens have flagged the implant maker as trading beneath estimated worth. A de-rating from earlier peaks has narrowed the premium the market once assigned it. Recurring services revenue continues to build behind the headline implant business. Cochlear (ASX:COH) is drawing a sharper market lens as sector conditions and company execution intersect across Australian equities. Cochlear (ASX:COH) has begun appearing on screens identifying Australian listed companie...

Continue reading
Kalkine
Neutral
31 Aug

Can Healthcare Stocks Shift Around Cochlear (ASX:COH)?

Highlights Annual earnings from the hearing implant maker landed ahead of the subdued expectations the market had set. Services and sound processor upgrades continue to build a recurring revenue layer beneath implant sales. The shares edged higher as the result removed a cloud that had lingered over the device sector. The latest local-market debate around healthcare stocks has brought Cochlear (ASX:COH) back into view, with operating detail carrying more weight than broad sentiment. Cochlear ...

Continue reading
Kalkine
Positive
27 Aug

Can Cochlear (ASX:COH) Rally Further on Profit Jump?

Highlights Cochlear shares jumped after annual profit landed at the upper end of guidance issued earlier in the year. A compression in gross margin and softer implant revenue had earlier triggered a guidance downgrade that weighed on sentiment. Forward guidance points to steady constant currency revenue growth and a recovery in underlying profit over the coming year. Cochlear (ASX:COH) [ASX 50] shares jumped in trading after the hearing implant group reported an annual profit outcome that lan...

Continue reading
Kalkine
Neutral
25 Aug

What Is Keeping Cochlear (ASX:COH) on Track?

Highlights Underlying profit finished well below the prior year yet still landed at the upper end of revised guidance Sound processor upgrades and services revenue continue to smooth an inherently lumpy earnings profile Emerging market tender timing and currency translation remain the least predictable variables Cochlear firmed after a full-year result reported earlier this month landed at the upper end of the guidance range the company had revised during the year, extending a run of construc...

Continue reading